Los Angeles, California 90095

  • Deficit/Hyperactivity Disorder


This proposal seeks to obtain preliminary data on the potential efficacy, tolerability, and feasibility of trigeminal nerve stimulation (TNS) as a treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). If successful, this open-label, exploratory, pilot study will provide a basis for a federal grant application and larger controlled trials.


Inclusion Criteria: - male and female youth age 9 to 14 years with DSM-IV ADHD, combined subtype as determined by Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS) and clinical interview - minimum scores of 12 on both the inattentive and hyperactive/impulsive subscales of the baseline ADHD-RS - Clinical Global Impression- Severity (CGI-S) score at baseline - no current medications with central nervous system (CNS) affects - parents able and willing to monitor proper use of the stimulation device and complete all required rating scales. Exclusion Criteria: - impaired functioning to a degree that requires immediate initiation of ADHD medication in the opinion of the parents and/or investigator; 2) current diagnosis of pervasive developmental disorder or major depression. - history of lifetime psychosis or mania - current suicidality - history of seizure disorder, tic disorder, or head injury with loss of consciousness.



Primary Contact:

James J. McGough, M.D.
Phone: 310-794-7841
Email: jmcgough@mednet.ucla.edu

Backup Contact:


Location Contact:

Los Angeles, California 90095
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: August 02, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.